Taken together, these results suggested that codon 72 allelism does not seem to have an impact on human cancer risk, especially for SCCHN, although Dumont et al (2003) had demonstrated that the Arg72 form of p53 was at least five times better at inducing apoptosis than the Pro72 variant. This evidence concerns the gene TP53 and cancer.